by Alicia Brown  , Caitlin Woodcock  , Kelly Cocallis  and Alan Robert Bowman

Received: 26 May 2022;  Published: 14 November 2022;  doi: 10.21926/obm.icm.2204050

Chronic pain affects around 28 million people in the UK. Those living with chronic pain can frequently experience internalised self-stigma and negative self-evaluations as a result of the pain itself and due to difficult life experiences. Previous research has found Compassion Focused Therapy to be effective for people living with long term health conditions like chronic pain. The current study sought to evaluate a routine Virtual Compassionate Living Group for patients with chronic pain on the measures of self-com [...]

by OBM Genetics Editorial Office

Received: 09 January 2023;  Published: 10 January 2023;  doi: 10.21926/obm.genet.2301176

An Interview with Dr. Yuri Shavrukov

by Jacques De Reuck  , Florent Auger  , Nicolas Durieux  , Claude-Alain Maurage  , Vincent Deramecourt  , Charlotte Cordonnier  , Florence Pasquier  , Didier Leys  and Regis Bordet

Received: 24 September 2020;  Published: 10 December 2020;  doi: 10.21926/obm.geriatr.2004142

The influence of cerebral amyloid angiopathy (CAA) in Alzheimer’s disease (AD) remains unexplored. The present post-mortem study investigated possible differences in the degree of hippocampal atrophy (HA) between AD patients with and without CAA using 7.0-tesla magnetic resonance imaging (MRI). Also, the incidence of the hippocampal cortical micro-infarcts (HCoMIs) and hippocampal cortical micro-bleeds (HCoMBs) is compared to those in the neocortex. The examined post-mortem brains included 30 AD-CAA cases and 20 AD [...]

by Alessia Bartolacci  , Fabrizio Stocchi  , Vilberto Stocchi  and Sabrina Donati Zeppa

Received: 17 November 2024;  Published: 08 April 2025;  doi: 10.21926/rpn.2502007

In recent years, there has been an alarming increase in the incidence of inflammatory bowel disease (IBD), which includes both Crohn's disease (CD) and ulcerative colitis (UC), particularly in Western countries. This chronic condition is intricately linked to the composition and health of the gut microbiota (GM) — a complex community of microorganisms residing in the gastrointestinal (GI) tract. Despite extensive research, the underlying pathogenesis of IBD remains poorly understood, making it a wide area of invest [...]

by Michael B. Keller  , Temesgen E. Andargie  and Sean Agbor-Enoh

Received: 16 March 2023;  Published: 26 June 2023;  doi: 10.21926/obm.transplant.2302190

Advances in the use of molecular biomarkers to guide management of lung transplant recipients are emerging. One such biomarker, donor-derived cell-free DNA (dd-cfDNA), has the potential to alter traditional approaches of lung transplant management, including the detection of acute rejection or infection, surveillance monitoring strategies, risk stratification of vulnerable patient populations and molecular phenotyping of various forms of allograft injury. The emergence of novel genetic and epigenetic approaches uti [...]

by Pier Alberto Testoni  and Sabrina Testoni

Received: 17 October 2019;  Published: 23 December 2019;  doi: 10.21926/obm.hg.1904042

Recurrent acute pancreatitis (RAP) is a clinical entity characterized by episodes of acute pancreatitis which occurs on more than one occasion. Recurrence of pancreatitis generally occurs in a setting of a normal anatomical and functional gland, however, a chronic disease at early stage may be found either on the occasion of the first episode of pancreatitis or during the follow-up. The etiology of RAP can be identified in up to 70% of cases; for the remaining cases the term “idiopathic” is used. Most common caus [...]

by OBM Genetics Editorial Office

Received: 07 July 2022;  Published: 13 July 2022;  doi: 10.21926/obm.genet.2203160

by Nicole Mölders

Received: 11 August 2020;  Published: 17 August 2020;  doi: 10.21926/aeer.2003001

by Mahmoud F. Elmorshedy  , Abualkasim Bakeer  and Dhafer Almakhles

Received: 14 February 2023;  Published: 09 May 2023;  doi: 10.21926/jept.2302017

The special design of linear induction machines (LIMs) leads to adverse effects caused by the longitudinal and end effects. These effects make the thrust control of the LIMs most attractive because its value decreases sharply with the speed increase. Thus, finite-state model predictive control (FS-MPC) is developed to increase the performance of the LIMs. However, the variable switching frequency is the main drawback of this control. Consequently, the main objectives of this paper are to propose FS-MPC with a const [...]

by Rene J. Duquesnoy

Received: 11 July 2018;  Published: 05 September 2018;  doi: 10.21926/obm.transplant.1803018

The Holy Grail to Clinical Transplant Tolerance is Paved with HLA Epitopes